Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + tetracycline dual therapy versus lansoprazole-based bismuth quadruple therapy for first-line Helicobacter pylori eradication
ChiCTR2300074693Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vonoprazan and tetracycline in Helicobacter pylori infection (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Successful eradication. Started Jun 2023; status: recruiting.
02
Drugs
vonoprazantetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2300074693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074693.